After a record-breaking August surge, volatility has made its way back to the Street. With COVID-19 continuing to impact the financial landscape and …
Stocks roared higher on Monday, but one legendary hedge fund manager isn’t breaking out the champagne just yet. Optimism that COVID-19’s spread may …
Written by Daniel Cohen and Scott Matusow Lately, many early stage developmental biotech companies have been going on some seriously epic runs. Karuna …
Written by Danny Cohen And Scott Matusow This past weekend at The Society for Immunotherapy of Cancer (SITC) Calithera Biosciences Inc (NASDAQ:CALA) presented a …
Written by Dan Cohen and Scott Matusow After consistent disappointments in the development of agents to treat metastatic triple-negative breast cancer (TNBC), novel …
Written by Dan Cohen and Scott Matusow These days, it seems as if every major pharmaceutical company is working on their own PD-1 targeted therapeutic regimen …
